Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Sasanlimab联合BCG治疗既往未接受过BCG治疗的高危非肌层浸润性膀胱癌:一项随机3期CREST试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03738-z
Shore, Neal D; Powles, Thomas B; Bedke, Jens; Galsky, Matthew D; Palou Redorta, Joan; Ku, Ja Hyeon; Kretkowski, Michal; Xylinas, Evanguelos; Alekseev, Boris; Ye, Dingwei; Guerrero-Ramos, Félix; Briganti, Alberto; Kulkarni, Girish S; Brinkmann, Julia; Calella, Anna-Maria; Cesari, Rossano; Eccleston, Anthony; Michelon, Elisabete; Vermette, Jennifer; Wei, Caimiao; Steinberg, Gary D